Efficacy of RCDOP regimen in the treatment of patients with diffuse large B-cell lymphoma

被引：0
|
作者：
曹怡文 [1 ]
机构：
[1] State Key Med Genomics Lab,Shanghai Hematol Instit
来源：
China Medical Abstracts(Internal Medicine) | 2018年 / 35卷 / 03期
关键词：
DLBCL; Efficacy of RCDOP regimen in the treatment of patients with diffuse large B-cell lymphoma;
D O I：
暂无
中图分类号：
R733.1 [网状内皮系统肿瘤];
学科分类号：
摘要：
Objective To investigate the efficacy of RCDOP(Rituximab, cyclophosphamide, liposome doxorubicin,vincristine and prednisone) regimen in patients with de novo diffuse large B-cell lymphoma (DLBCL), especially in those patients with multiple extra-nodal involvement or Bulky diseases.Methods A total of 87 newly diag-
引用
收藏
页码：187 / 187
页数：1
相关论文
共 50 条
  • [31] An evaluation of polatuzumab vedotin for the treatment of patients with diffuse large B-cell lymphoma
    Walji, Moneeza
    Assouline, Sarit
    EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (09) : 933 - 942
  • [32] Trofosfamide in the treatment of elderly or frail patients with diffuse large B-cell lymphoma
    Witte, Hanno M.
    Riecke, Armin
    Mayer, Thomas
    Bartscht, Tobias
    Rades, Dirk
    Lehnert, Hendrik
    Merz, Hartmut
    Fetscher, Sebastian
    Biersack, Harald
    Gebauer, Niklas
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (01) : 129 - 136
  • [33] Treatment outcomes in older patients with systemic diffuse large B-cell lymphoma
    Brien, Caragh
    Zareen, Ferkhanda
    Bruce, David
    Jayaprakash, Ram
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 : 181 - 182
  • [34] R-CEOP 1-8 regimen for treatment of elderly patients with diffuse large B-cell lymphoma
    Bascialla, Linda
    Marelli, Maria
    Chini, Claudio
    Proserpio, Ilaria
    Gueli, Rossana
    Pinotti, Graziella
    ANNALS OF ONCOLOGY, 2006, 17 : 200 - 201
  • [35] New treatment options in elderly patients with Diffuse Large B-cell Lymphoma
    Arcari, Annalisa
    Cavallo, Federica
    Puccini, Benedetta
    Vallisa, Daniele
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [36] Diagnosis and treatment in patients with B-cell lymphoma unclassified that is intermediate between diffuse large B-cell lymphoma and Burkitt's lymphoma
    Baryakh, E. A.
    Misyurina, A. E.
    Kovrigina, A. M.
    Obukhova, T. N.
    Gemdzhyan, E. G.
    Vorobyev, V. I.
    Mangasarova, Ya. K.
    Polyakov, Yu. Yu.
    Magomedova, A. U.
    Klyasova, G. A.
    Misyurin, V. A.
    Yatsyk, G. A.
    Shevelev, A. A.
    Kostina, I. E.
    Vorobyev, A. I.
    Kravchenko, S. K.
    TERAPEVTICHESKII ARKHIV, 2015, 87 (08) : 77 - 85
  • [37] Efficacy of rituximab combined with CHOP for treating patients with diffuse large B-cell lymphoma
    Hu, Xin
    Zeng, Min
    Yang, Shun-e
    Liang, Xiao
    Ding, Shan-shan
    Guo, Li
    Li, Shan
    Wen, Shu-juan
    MEDICINE, 2017, 96 (45)
  • [38] The Gut Microbiome Correlated to Chemotherapy Efficacy in Diffuse Large B-Cell Lymphoma Patients
    Xu, Zhuo-Fan
    Yuan, Li
    Zhang, Yan
    Zhang, Wei
    Wei, Chong
    Wang, Wei
    Zhao, Danqing
    Zhou, Daobin
    Li, Jingnan
    HEMATOLOGY REPORTS, 2024, 16 (01) : 63 - 75
  • [39] Molecular Classification and Treatment of Diffuse Large B-Cell Lymphoma and Primary Mediastinal B-Cell Lymphoma
    Roschewski, Mark
    Phelan, James D.
    Wilson, Wyndham H.
    CANCER JOURNAL, 2020, 26 (03): : 195 - 205
  • [40] Translating the Biology of Diffuse Large B-cell Lymphoma Into Treatment
    Danilov, Alexey, V
    Magagnoli, Massimo
    Matasar, Matthew J.
    ONCOLOGIST, 2022, 27 (01): : 57 - 66
12345